Stock Research for ALIM

ALIM
Current Price

$1.2698


Latest Update: 2018-01-16 16:00:00

High
$ 1.2700
Low
$ 1.2698
Close
$ 1.2700
Volume
3580
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

ALIM Stock Chart & Research Data

The ALIM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ALIM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ALIM Due diligence Resources & Stock Charts

The ALIM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ALIM Detailed Price Forecast - CNN Money CNN View ALIM Detailed Summary - Google Finance
Yahoo View ALIM Detailed Summary - Yahoo! Finance Zacks View ALIM Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View ALIM Trends & Analysis - Trade-Ideas Barrons View ALIM Major Holders - Barrons
NASDAQ View ALIM Call Transcripts - NASDAQ Seeking View ALIM Breaking News & Analysis - Seeking Alpha
Spotlight View ALIM Annual Report - CompanySpotlight.com OTC Report View ALIM OTC Short Report - OTCShortReport.com
TradeKing View ALIM Fundamentals - TradeKing Charts View ALIM SEC Filings - Bar Chart
WSJ View Historical Prices for ALIM - The WSJ Morningstar View Performance/Total Return for ALIM - Morningstar
MarketWatch View the Analyst Estimates for ALIM - MarketWatch CNBC View the Earnings History for ALIM - CNBC
StockMarketWatch View the ALIM Earnings - StockMarketWatch MacroAxis View ALIM Buy or Sell Recommendations - MacroAxis
Bullish View the ALIM Bullish Patterns - American Bulls Short Pains View ALIM Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View ALIM Stock Mentions - StockTwits PennyStocks View ALIM Stock Mentions - PennyStockTweets
Twitter View ALIM Stock Mentions - Twitter Invest Hub View ALIM Investment Forum News - Investor Hub
Yahoo View ALIM Stock Mentions - Yahoo! Message Board Seeking Alpha View ALIM Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for ALIM - SECform4.com Insider Cow View Insider Transactions for ALIM - Insider Cow
CNBC View ALIM Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ALIM - OTC Markets
Yahoo View Insider Transactions for ALIM - Yahoo! Finance NASDAQ View Institutional Holdings for ALIM - NASDAQ


Stock Charts

FinViz View ALIM Stock Insight & Charts - FinViz.com StockCharts View ALIM Investment Charts - StockCharts.com
BarChart View ALIM Stock Overview & Charts - BarChart Trading View View ALIM User Generated Charts - Trading View


Latest Financial News for ALIM

Alimera Sciences Refinances Debt With New $40 Million Debt Facility From Solar Capital
Posted on Monday January 08, 2018

ATLANTA, Jan. 08, 2018-- Alimera Sciences, Inc., a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that it has ...


Alimera Sciences Receives Acceptance of Filing to Obtain Approval for ILUVIEN® Non-Infectious Posterior Uveitis Indication in Europe
Posted on Thursday January 04, 2018

ATLANTA, Jan. 04, 2018-- Alimera Sciences, Inc., a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that it received validation of a Type II variation ...


ETFs with exposure to Alimera Sciences, Inc. : December 18, 2017
Posted on Monday December 18, 2017

Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)


Alimera Sciences Announces Patients Now Being Treated With ILUVIEN® In Ireland
Posted on Monday December 11, 2017

ATLANTA, Dec. 11, 2017-- Alimera Sciences, Inc., a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that the first patients in Ireland were treated ...


Alimera Sciences to Report Third Quarter 2017 Results November 1st, 2017
GlobeNewswire (press release) - Oct 25, 2017
ATLANTA, Oct. 25, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences (NASDAQ:ALIM), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that it will release its financial results for the third quarter ...

Alimera Sciences Announces Patients Now Being Treated With ILUVIEN® In Ireland
GlobeNewswire (press release) - Dec 11, 2017
ATLANTA, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that the first patients in Ireland were treated ...

Alimera Sciences Announces Real-World Audit Data Supporting the Positive ...
GlobeNewswire (press release) - Jul 25, 2017
ATLANTA, July 25, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that data from an ongoing audit of real-world U.K ...

Alimera Sciences Refinances Debt With New $40 Million Debt Facility From Solar ...
GlobeNewswire (press release) - Jan 8, 2018
“Working with Solar Capital provides us with a long-term partner and a stable debt facility over the next few years,” said Dan Myers, Alimera's chief executive officer. “Further, eliminating the restrictive liquidity covenants in our existing loan will ...
Alimera Sciences (ALIM) Lifted to “Hold” at Zacks Investment Research - StockNewsTimes

Enter a stock symbol to view the stock details.